Dr. Whitsett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave # 7029
Cincinnati, OH 45229
Summary
- Dr. Whitsett's laboratory discovered surfactant proteins B and C, cloned the genes encoding the surfactant proteins A, B, C, and D, Scgb1a1, TTF-1 and others and utilized transgenic mouse models to delete and mutate these genes in transgenic mice. They identified transcriptional networks regulating lung morphogenesis and perinatal lung maturation contributing to the understanding of the roles of TTF-1, CEBPα, SOX2, SOX17, FOXA1, FOXA2, FOXA3, SPDEF, KLF5, CDC42 and others using both in vitro and in vivo methods. They identified multiple transcription factors regulating goblet cell differentiation airway epithelial cells including critical role of SPDEF, FOXA3 and airway goblet cells controlling innate immunity. They produced transgenic mouse models for conditional deletion and expression of genes involved in lung development, disease, and repair. They have generated transgenic models of pulmonary adenocarcinoma and explored the role of transcription factors mediating pulmonary adenocarcinoma in vivo and in vitro. They utilized RNA-Seq, microarray, Chip-Seq in the application of Nex-Gen sequencing and bioinformatics to identify and understand networks involved in the regulation of lung development and disease using clinical sample, as well as in vitro and in vivo models.
Dr. Whitsett has a long interest in training both in the clinical setting in “Neonatology” and in “Pulmonary Biology” and has contributed to the direct training of more than 80 graduate or post-graduate students in his laboratory. The scope of his work is represented in several recent reviews. Initial discoveries from his laboratory provided early insights into the genes and proteins critical for surfactant function including ABCA3, SFTPC, SFTPB, SFTPA, SFTPD.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Neonatal-Perinatal Medicine, 1976 - 1978
- Icahn School of Medicine at Mount Sinai/Kravis Children'sResidency, Pediatrics, 1973 - 1976
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1973
Certifications & Licensure
- OH State Medical License 1978 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
Awards, Honors, & Recognition
- 2018 Edward Livingston Trudeau Medalist American Thoracic Society, 2018
- P&S Alumni Gold Medal Award Columbia University, 2018
- Virginia Apgar Award American Academy of Pediatrics, 2015
- Join now to see all
Publications & Presentations
PubMed
- 258 citationsSURFACTANT PROTEIN-A-DEFICIENT MICE ARE SUSCEPTIBLE TO PSEUDOMONAS AERUGINOSA INFECTIONAnn Marie LeVine, Kim E. Kurak, Michael D. Bruno, James M. Stark, Jeffrey A. Whitsett
American Journal of Respiratory Cell and Molecular Biology. 1998-10-01 - 108 citationsDecreased Surfactant Protein A in Patients with Bacterial PneumoniaRobert P. Baughman, Richard I. Sternberg, William M. Hull, James A. Buchsbaum, Jeffrey A. Whitsett
The American Review of Respiratory Disease. 1993-03-01 - 98 citationsTumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein.Jonathan R. Wispé, Jean C. Clark, Barbara B. Warner, D Fajardo, W E Hull
The Journal of Clinical Investigation. 1990-12-01
Press Mentions
- Defective Mesenchymal Bmpr1a-Mediated BMP Signaling Causes Congenital Pulmonary CystsJune 10th, 2024
- Fgf10 Signaling-Based Evidence for the Existence of an Embryonic Stage Distinct from the Pseudoglandular Stage During Mouse Lung DevelopmentOctober 22nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: